Edwards Lifesciences Corp

Edwards Lifesciences, a global medical technology leader, specializes in developing advanced solutions for structural heart conditions and critical care/surgical monitoring. Operating across the U.S., Europe, Japan, and other international markets, the company provides transcatheter heart valve therapies for minimally invasive replacement and repair, specifically targeting mitral and tricuspid valve diseases. Its innovative offerings include the PASCAL and Cardioband transcatheter valve repair systems. Beyond transcatheter devices, Edwards Lifesciences manufactures a comprehensive range of surgical structural heart products, such as the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex replacements, and the HARPOON Beating Heart Mitral Valve Repair System for degenerative mitral regurgitation. The firm also delivers crucial critical care solutions, including sophisticated hemodynamic monitoring systems for assessing cardiac function and fluid balance in surgical and ICU settings, alongside the Acumen Hypotension Prediction Index software, which proactively warns clinicians about impending dangerously low blood pressure. Products are distributed via an in-house sales team and independent distributors. Established in 1958, Edwards Lifesciences Corporation is headquartered in Irvine, California.